Document is current
Any future updates will be listed below
-
Authors
Gunduz, Eren
Ulas, Turgay
Ozkalemkas, Fahir
Toprak, Selami Kocak
Karakulak, Elifcan Aladag
Ar, Muhlis Cem
Gulbas, Zafer
Ozkocaman, Vildan
Aydogan, Merve
Buyukasik, Yahya
Cerme, Melis Dila Ozer
Mehtap, Ozgur
Kucur, Damlanur
Kaya, Emin
Yavasoglu, Irfan
Besisik, Sevgi Kalayoglu
Ersal, Tuba
Yuksel, Merve
Hacioglu, Sibel
Hacibekiroglu, Tuba
Kaya, Ahmet
Sakci, Elif
Yuksel, Meltem Kurt
Ozet, Gulsum
Cagliyan, Gulsum Akgun
Hasanzade, Ulviyya
Salim, Ozan
Pepeler, Mehmet Sezgin
Turgut, Mehmet
Kurekci, Derya Deniz
Giden, Asli Odabasi
Sener, Seray
Calika, Sinem
Dal, Mehmet Sinan
- License Information
-
More Information
Article History
Received: 18 July 2025
Accepted: 26 January 2026
First Online: 20 February 2026
Declarations
:
: The study was approved by the Clinical Research Ethics Committee of Eskisehir Osmangazi University (Approval number: 42/, date: 04 October 2022) and was carried out in accordance with the legal and regulatory requirements, the principles of Good Clinical Practice and Declaration of Helsinki. This study was conducted as a retrospective analysis of previously collected data. Therefore, informed consent was not applicable, as no new patient interventions or identifiable personal data were involved.
: Not applicable.
: S. Sener and S.S. Calika are employees of Pfizer. Other authors declare no conflict of interest related to this work.
